Malignant lymphoma after diphenylhydantoin (dilantin) therapy

No abstract is available for this paper.

• Publication year

  1975

• Venue

  Cancer

• Publication date

  1975-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(197510)36:4<1359::AID-CNCR2820360426>3.0.CO;2-LPMID 1175133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Malignant lymphogranulomatosis and anticonvulsant therapy.

  2009cited by this paper
• Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

  1975cited by this paper
• Letter: Lymphoma and anticonvulsive therapy.

  1974cited by this paper
• Lymphoma and Anticonvulsive Therapy

  1974cited by this paper
• Are anticonvulsants oncogenic?

  1974cited by this paper
• Immunologic characterization of human malignant lymphomas

  1974cited by this paper
• Transplacental Carcinogenesis

  1974cited by this paper
• Diphenylhydantoin and selected congenital malformations.

  1973cited by this paper
• Non-Hodgkin's lymphoma in childhood: epidemiologic features.

  1973cited by this paper
• Risk of cancer in renal-transplant recipients.

  1973cited by this paper
• Immunodeficiency disease and malignancy. Various immunologic deficiencies of man and the role of immune processes in the control of malignant disease.

  1972cited by this paper
• Is phenytoin carcinogenic?

  1972cited by this paper
• Immunological Abnormalities and Hydantoins

  1972cited by this paper
• PHENYTOIN AND THE PSEUDOLYMPHOMA SYNDROME

  1971cited by this paper
• Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin).

  1971cited by this paper
• Vaginal cancer after maternal treatment with synthetic estrogens.

  1971cited by this paper
• Transplacental chemical carcinogenesis in man.

  1971cited by this paper
• Role of Immunologic Disturbance in Human Oncogenesis: Some Facts and Fancies

  1971cited by this paper
• Effect of dilantin in mice

  1970cited by this paper
• Malignant lymphoma associated with hydantoin drugs.

  1970cited by this paper
• Pseudolymphoma induced by diphenylhydantoin.

  1970cited by this paper
• Essential relationship between the lymphoid system, immunity, and malignancy.

  1969cited by this paper
• Hodgkin's disease in childhood: an epidemiologic study.

  1969cited by this paper
• Hodgkin's Disease in Childhood: An Epidemiologic Study

  1969cited by this paper
• Hydantoin-induced pseudo-pseudolymphoma.

  1968cited by this paper
• The development of Hodgkin's disease and lymphoma during anticonvulsant therapy.

  1966cited by this paper
• DIPHENYLHYDANOIN-INDUCED HYPERSENSITIVITY REACTION.

  1965cited by this paper
• Malignant Lymphomas Following Allogenic Disease: Transition from an Immunological to a Neoplastic Disorder

  1965cited by this paper
• Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically and pathologically malignant lymphomas

  1959cited by this paper

• los linfomas no hodgkinianos

  2016cites this paper
• Lymphoma and Pseudolymphoma and Drug Reactions

  2015cites this paper
• T-Cell Pseudolymphoma Presenting in a Lichenoid and Nodular Pattern

  2014cites this paper
• Hiperplasia linfoide cervical por difenilhidantoína.

  2013cites this paper
• Hairy cell leukaemia occurring during phenytoin (diphenylhydantoin) treatment.

  2009cites this paper
• Myelomatosis after phenytoin therapy: a chance association?

  2009cites this paper
• Multiple myeloma after phenytoin therapy.

  2009cites this paper
• Non‐Hodgkin's Lymphomas

  2007cites this paper
• Generalized lymphadenopathy

  2007cites this paper
• Risk of Multiple Myeloma following Medication Use and Medical Conditions: A Case-Control Study in Connecticut Women

  2006cites this paper
• Chapter 9 – Differential Diagnosis

  2006cites this paper
• Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma

  2005cites this paper
• Medication use and risk of non-Hodgkin's lymphoma.

  2005cites this paper
• Cancer risk in people with epilepsy: the role of antiepileptic drugs.

  2004cites this paper
• Acetylation and oxidation phenotypes in malignant lymphoma

  2004cites this paper
• Impact of phenytoin therapy on the skin and skin disease

  2004cites this paper
• Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women

  2004cites this paper
• Acute myelogenous leukemia following treatment with cyclosporin A in a nephrotic patient.

  2002cites this paper
• Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.

  2002cites this paper
• Factores de riesgo para los linfomas no hodgkinianos

  2001cites this paper
• Atypical Lymphoproliferative Diseases.

  2000cites this paper
• Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.

  1999cites this paper
• [Cutaneous pseudolymphoma caused by carbamazepine].

  1998cites this paper
• Cutaneous pseudolymphomas.

  1998cites this paper
• Atypical lymphoid infiltrates arising in cutaneous lesions of connective tissue disease.

  1997cites this paper
• Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis.

  1996cites this paper
• Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

  1996cites this paper
• EBV‐positive non‐Hodgkin's lymphoma developing after phenytoin therapy

  1996cites this paper
• Risks of Non‐Hodgkin's Lymphoma, Multiple Myeloma, and Leukemia Associated with Common Medications

  1996cites this paper
• Perspective on the carcinogenic potential of phenytoin based on rodent tumor bioassays and human epidemiological data

  1996cites this paper
• [Drugs implicated in iatrogenic lung pathology. The STudy Group of Iatrogenic Lung Pathology].

  1996cites this paper
• Lymphoblastic Lymphoma Following Prenatal Exposure to Phenytoin

  1996cites this paper
• Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma.

  1995cites this paper
• Pleural and mediastinal disorders related to drug use.

  1995cites this paper
• Nonhormonal drugs and cancer.

  1995cites this paper
• Phenytoin-related immunodeficiency associated with Loeffler's syndrome.

  1995cites this paper
• Carbamazepine Hypersensitivity Syndrome: Report of 4 Cases and Review of the Literature

  1995cites this paper
• Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns.

  1995cites this paper
• Etiology, Clinical Associations, and the Possibility of Prevention of Childhood Malignancies

  1994cites this paper
• Comparative carcinogenicity of 5,5-diphenylhydantoin with or without perinatal exposure in rats and mice.

  1993cites this paper
• Autoimmune and iatrogenic causes of lymphadenopathy.

  1993cites this paper
• Bone marrow involvement in phenytoin induced 'pseudolymphoma'.

  1993cites this paper
• Immunological Adverse Effects of Anticonvulsants

  1993cites this paper
• Otolaryngologic manifestations of phenytoin toxicity.

  1992cites this paper
• Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County.

  1992cites this paper
• Phenytoin‐induced pseudolymphoma. A report of a case and review of the literature

  1992cites this paper
• Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sézary syndrome.

  1992cites this paper
• Applications of molecular physics 'biotechnology' to the rational design of an improved phenytoin analogue.

  1992cites this paper
• Generalized nodular cutaneous pseudolymphoma associated with phenytoin therapy. Use of T-cell receptor gene rearrangement in diagnosis and clinical review of cutaneous reactions to phenytoin.

  1992cites this paper
• Nebenwirkungen der Antiepileptika - Teil II

  1991cites this paper
• The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland.

  1991cites this paper
• Possible Causes of Cancer in Transplant Patients

  1991cites this paper
• (56) Phenytoin‐induced pseudolymphoma

  1991cites this paper
• Cancer in children of epileptic mothers and the possible relation to maternal anticonvulsant therapy.

  1990cites this paper
• Lymphoproliferative disorders associated with carbamazepine.

  1990cites this paper
• The pathology of Hodgkin's disease.

  1990cites this paper
• Hodgkin's disease complicating neuronal ceroid-lipofuscinosis.

  1989cites this paper
• Serum immunoglobulins, complement levels and lymphocyte subpopulations in phenytoin-treated epileptic patients.

  1989cites this paper
• Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.

  1989cites this paper
• A case of amyloidosis associated with diphenylhydantoin therapy.

  1989cites this paper
• Erythroderma with Generalized Lymphadenopathy Induced by Phenytoin

  1989cites this paper
• Cancer among epileptic patients exposed to anticonvulsant drugs.

  1989cites this paper
• Lack of carcinogenicity of phenytoin in (C57BL/6 x C3H)F1 mice.

  1988cites this paper
• Anticonvulsant-induced marrow suppression and immune thrombocytopenia.

  1988cites this paper
• Cutaneous and immunologic reactions to phenytoin.

  1988cites this paper
• The Effect of Diphenylhydantoin and Cortisol on the Cell Cycle 1

  1988cites this paper
• Phenytoin syndrome developing after administration of dilantin for an enflurane-induced seizure.

  1988cites this paper
• Diphenylhydantoin-induced lymphocytic interstitial pneumonia.

  1986cites this paper
• The occurrence of malignant tumors in immunosuppressed states.

  1986cites this paper
• Pilot study of phenytoin in rheumatoid arthritis.

  1986cites this paper
• Does prolonged use of diphenylhydantoin predispose to pulmonary sarcoidosis?

  1986cites this paper
• Effect of Chronic Anticonvulsant Monotherapy on Lymphocyte Subpopulations in Adult Epileptic Patients

  1985cites this paper
• [Macrocytic anemia due to folic acid deficiency and non-Hodgkin's lymphoma associated with prolonged diphenylhydantoin ingestion].

  1985cites this paper
• Generalized Pruritus as a Presenting Symptom of Phenytoin‐induced Hodgkin's Disease

  1985cites this paper
• Isolated malignant lymphoma of the jejunum and long-term diphenylhydantoin therapy.

  1985cites this paper
• Cutaneous pseudolymphomas.

  1985cites this paper
• Allograft Transplant cancer Registry

  1984cites this paper
• Non-Hodgkin's lymphomas.

  1984cites this paper
• Genetic Bioassay Data on Some Known or Suspected Human Carcinogens

  1983cites this paper
• Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method.

  1983cites this paper
• [Hodgkin's disease in an epileptic treated with hydantoins].

  1983cites this paper
• Phenytoin-Induced Lymphadenopathy

  1983cites this paper
• Genetic Toxicology of Some Known or Suspected Human Carcinogens

  1983cites this paper
• Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy.

  1983cites this paper
• [Histocytology of malignant non-Hodgkin's lymphoma in the child. Study of 161 cases typed according to the Kiel classification].

  1982cites this paper
• Transient antibody deficiency and abnormal t-suppressor cells induced by phenytoin.

  1982cites this paper
• [Effect of neurotransmitters and psychotropic drugs on the immune system. Mediator role of hormones and clinical implications].

  1982cites this paper
• [Drug-induced enteropathies].

  1982cites this paper
• Recurrenced lymphadenopathy of unknown origin: Report of a case

  1982cites this paper
• NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas.

  1981cites this paper
• Phenytoin-induced lymphadenopathy appearing as a nasopharyngeal malignant neoplasm.

  1981cites this paper
• Cancer, cholesterol, carotene, and tocopherol.

  1981cites this paper
• A case of angio-immunoblastic lymphadenopathy with dysproteinemia related to allopurinol.

  1981cites this paper
• Non-Hodgkin's lymphoma in systemic lupus erythematosus: report of 4 cases with ultrastructural studies in 2.

  1981cites this paper
• Carbamazepine. Pharmacology and clinical uses.

  1981cites this paper
• Premalignant lymphoid hyperplasia preceding and coexisting with malignant lymphoma in the skin.

  1981cites this paper
• Atypical lymphadenopathies of the head and neck.

  1981cites this paper
• A proposed mechanism of production of the autoimmune and lymphoproliferative side-effects of beta-adrenergic-site-blocking drugs and hydantoin anticonvulsants.

  1981cites this paper
• Cancer in the fetal hydantoin syndrome.

  1981cites this paper
• A Multidisciplinary Approach to Non-Hodgkin's Lymphomas

  1981cites this paper